Nutrition, Diabetes and Pulmonary TB/HIV
- Conditions
- TuberculosisHIVDiabetes
- Interventions
- Dietary Supplement: MultimicronutrientsDietary Supplement: Energy and proteins
- Registration Number
- NCT00311298
- Lead Sponsor
- University of Copenhagen
- Brief Summary
We propose a randomised trial among pulmonary TB patients, examined and treated as part of the national TB control programme (WHO, 2003). The aim is to improve TB treatment outcome in high TB and HIV burden countries. The overall objective of the proposed trial is to assess the effect of nutritional support on TB treatment outcomes, and to assess the role of diabetes on risk and severity of TB, and TB treatment outcomes. The study will be conducted in Mwanza Tanzania. All patients will initially be examined for HIV and diabetes. A total of 500 found pulmonary TB smear-positive (PTB+) and HIV positive (HIV+) will be randomised to a daily supplement of 1 versus 6 energy-protein bars throughout treatment, both with full multi-micronutrient (MN) content. A total of 1500 found pulmonary TB smear-negative (PTB-, irrespective of HIV status) and PTB+ and HIV negative (HIV-) will be randomised to 1 daily energy-protein bar containing either low or high MN content.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1250
- New sputum smear positive or negative pulmonary TB patients
- pregnant, terminally ill, other serious diseases (except HIV and diabetes), non-residents
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description No micronutrients Multimicronutrients Biscuit without additional micronutrients Micronutrients Multimicronutrients Biscuit with additional micronutrients 1 biscuit Energy and proteins 1 biscuit with micronutrients 6 biscuits Energy and proteins 1 biscuit with micronutrients, plus 5 biscuits without additional micronutrients
- Primary Outcome Measures
Name Time Method Weight gain 2 and 5 months
- Secondary Outcome Measures
Name Time Method CD4 count 2 and 5 months Serum acute phase reactants 2 months Mortality 12 month Grip strength 2 and 5 months Arm muscle and arm fat areas 2 and 5 months Physical activity 2 and 5 months HIV load 2 months
Trial Locations
- Locations (1)
Mwanza Medical Centre, NIMR
🇹🇿Mwanza, Tanzania